+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Immunotherapy in Oncology Startup Identification

  • ID: 5116502
  • Report
  • June 2020
  • Region: Global
  • 280 Pages
  • Knowmade

Report’s Key Features

  • PDF with > 280+ slides
  • Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
  • Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
  • Description of the startups and their pipeline, funding rounds and subsidies.
  • Presentation of all their published patent families.
  • Description of key people and their background.

Over 110 startups working in the field of Onco-Immunotherapy were identified

Cancer Immunotherapy is a very dynamic technological field and the global market is expected to grow and reach US$ 126.9 billion by 2026, with a CAGR of 9.6% from 2019 to 2026. With an increasing number of people with cancer (17 million of new cases of cancer worldwide) and the need of new treatments, the immunotherapy domain sees the arrival of numerous startups every year. In this highly diverse and rapidly changing ecosystem, it is crucial to identify new players and monitor their activities to determine opportunities, threats, potential partnerships and collaborations. Because of their small size and technological diversity, these young companies are hard to identify by conventional approaches (web searches, workshops etc.).

In this report, the publisher has therefore investigated Onco-Immunotherapy-related patents in order to identify startups through their patent filings. More than 110 startups incorporated between 2010 and 2019 were thus identified, and for over 50 of them, the report describes their main activity, products, patents, and key people among their staff. This study reveals that Cell Adoptive Transfer (e.g. CAR-T cell) is by far the technology explored the most by startups working in the field of immunotherapy in oncology. Immune checkpoint inhibitor/modulator, bispecific antibody and vaccine are also technologies of interest for some startups identified.

Detecting hidden companies:

Looking at patent documents makes it possible to identify companies that do not communicate much or even at all. It is a good way to detect companies that could not be found using more conventional methods (e.g. trade fairs, conferences, web searches, etc.).

Assessing the technology:

Technology is one of the keys to a startup’s success and being able to understand and assess it is highly valuable. The specification of a patent document includes a lot of technical information that can be used to determine the advantages brought by new inventions. The patent claims can also be used to determine the protection the applicant is asking for, and therefore where its interest resides.

Identifying the key people:

The success of a startup is strongly linked to the team that composes it. It is therefore important to know the founders and inventors to assess the odds of its success. Patents enable the identification of inventors inside the companies. These inventors are technical experts who have laid the foundation of the technology the startup is developing. Describing the background of key people can help in understanding the startup project, and their history can reveal the extent of the know-how they have accumulated.

Startup Identification

Startups have been identified by screening the patent documents published in 2019/2020 claiming Immunotherapy in Oncology. For each startup identified, the report provides a complete description of its activity and pipeline, with a link for ongoing clinical trials. Information about funding rounds and subsidies are also described.

Patent Description

This report includes a detailed description of all the patents filed by identified startups. The elements provided in each overview slide provide essential information to quickly understand the patented technology. For each patent family described, the publication number of Granted/Registered and Pending members are provided, as well as the abstract, the first claim, relevant information about the invention and the most relevant figure explaining how the invention can be carried out.

Key People Description

This report includes a description of the key people and/or inventors involved in each selected startup. Knowing the key people behind a startup helps assessing its chances of success by determining their individual strength and their complementarity. This report is focused on the description of the people who have a technical background. For each key person, the report shows a summary of their educational background, employment history, as well as their other current activities and a link to their LinkedIn profiles.

Note: Product cover images may vary from those shown


  • Objectives of the report
  • Scope of the report


  • Patent search, selection and analysis
  • Search strategy
  • Terminologies for patent analysis
  • Segmentation


  • Startups mapping
  • Key facts
  • Summary table of the identified companies
  • Summary table of companies with little information available


  • 59 Startup profiles


Note: Product cover images may vary from those shown


For patent landscape analysis, the patent information is extracted from the FamPat worldwide patent database (Questel-ORBIT) which provides 100+ million patent documents from 95 worldwide patent offices.

The search strategy combines keyword-based searches with expert review and manual screening of the patents. Keywords are searched in the title, abstract, claims and description. Relevant IPC (International Patent Classification) and CPC (Cooperative Patent Classification) are also used for the patent search. The dataset of identified patents is manually cleaned of non-relevant patents. Citing and cited patents of selected relevant patents are also included in the search strategy. The search strategy (keywords and search equations) and the dataset of selected patents is provided in our reports.

The publisher's analysts (PhD team) combine their technical and patent expertise with powerful analytics tools and proprietary methodologies to deliver the most relevant patent analyses.